Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bydureon
Pharma
AstraZeneca gets leg up with latest FDA nod for diabetes drug
The approval provides a point of differentiation for AstraZeneca in the competitive GLP-1 market, with Bydureon BCise approved for children.
Nick Paul Taylor
Jul 27, 2021 6:07am
AstraZeneca posts phase 3 data on once-weekly diabetes drug
Jun 28, 2021 12:37pm
ADA: AZ unveils possible new option for children with T2D
Jun 25, 2021 11:30am
Novo’s oral semaglutide could disrupt diabetes coverage: analyst
Mar 5, 2019 12:05pm
AZ reaffirms $40B goal by 2023—almost twice its 2018 forecast
Nov 8, 2018 11:45am
Europe follows FDA suit with approval spree this week
Aug 31, 2018 9:50am
